Form 8-K - Current report:
SEC Accession No. 0001193125-23-251085
Filing Date
2023-10-05
Accepted
2023-10-05 07:32:01
Documents
12
Period of Report
2023-10-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d553975d8k.htm   iXBRL 8-K 29307
  Complete submission text file 0001193125-23-251085.txt   149675

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hznp-20231005.xsd EX-101.SCH 2886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20231005_lab.xml EX-101.LAB 17167
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20231005_pre.xml EX-101.PRE 10812
6 EXTRACTED XBRL INSTANCE DOCUMENT d553975d8k_htm.xml XML 3296
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 231309823
SIC: 2834 Pharmaceutical Preparations